Cathy Cantalloube

A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study

James McCarthy, Thomas Rückle, Elhadj Djeriou et al. · Malaria Journal · 2016 · 125 citations · Full text

Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study

Jana Held, Christian Supan, Carmen L. Ospina Salazar et al. · The Lancet Infectious Diseases · 2015 · 88 citations

Global Health, Malaria, Clinical Epidemiology +6

Bronchopulmonary Disposition of the Ketolide Telithromycin (HMR 3647)

Claudette Muller‐Serieys, Paul Soler, Cathy Cantalloube et al. · Antimicrobial Agents and Chemotherapy · 2001 · 67 citations · Full text

A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria

Adoke Yeka, Rella Zoleko‐Manego, Serge Ouoba et al. · Malaria Journal · 2021 · 56 citations · Full text

Pharmacokinetics of the ketolide telithromycin after single and repeated doses in patients with hepatic impairment

Cathy Cantalloube, Vijay O. Bhargava, E. Sultan et al. · International Journal of Antimicrobial Agents · 2003 · 30 citations

Hepatology, Liver Physiology, Ketolide Telithromycin +9